|
Michael Casey has served as a member of Allos' Board of Directors since 2002. Since February 2002, Mr. Casey has been a self-employed consultant to the pharmaceutical industry. Previously, Mr. Casey served four years as president, chief executive officer and chairman of Matrix Pharmaceutical, Inc., until Chiron acquired the company in February 2002. Prior to joining Matrix, Mr. Casey was president of two divisions of Schein Pharmaceutical, Inc. from 1995 to 1997, and president and chief operating officer of Genetic Therapy, Inc. from 1993 to 1995 until it was sold to Sandoz (Novartis). Mr. Casey also spent 25 years with Johnson & Johnson, including vice-president of sales and marketing of Ortho Pharmaceutical Corporation and president of McNeil Pharmaceuticals. Mr. Casey is a director of Celgene Corp., Orthologic Corp., Durect Corp., and Cholestech Corporation. | 